AJUBA promotes the proliferation, invasion and migration of NSCLC cells by activating the ERK/β-catenin pathway

Abstract Accumulating evidence indicates that AJUBA acts as a potential target for new therapeutics to treat cancers. Nevertheless, the role of AJUBA in non-small cell lung cancer (NSCLC) remains unclear. In the current study, immunohistochemistry (IHC) showed that expression of AJUBA was upregulate...

Full description

Saved in:
Bibliographic Details
Main Authors: Lianyue Qu, Fan Wang, Yuxiang Wang, Zixuan Li
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-98156-z
Tags: Add Tag
No Tags, Be the first to tag this record!